Bright Minds Biosciences Inc. (CSE:DRUG)

Bright Minds Biosciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 21, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	360	7	8	28	107	-
Market Cap Growth	3710.83%	-19.09%	-71.17%	-73.71%	-	-
Enterprise Value	303	0	0	19	85	-
Last Close Price	51.16	1.47	2.15	8.50	45.20	-
PB Ratio	6.18	1.19	1.23	2.67	5.51	-
P/TBV Ratio	6.24	1.19	1.23	2.67	5.51	-
Debt / Equity Ratio	0.00	0.02	0.01	0.01	-	-
Quick Ratio	125.59	10.91	24.16	8.00	31.12	5.30
Current Ratio	126.15	11.32	24.26	8.11	31.38	5.82
Return on Equity (ROE)	-3.35%	-46.18%	-86.02%	-99.95%	-85.94%	-124.04%
Return on Assets (ROA)	-4.93%	-25.19%	-47.45%	-57.32%	-51.52%	-61.70%
Return on Capital (ROIC)	-5.02%	-26.53%	-51.86%	-61.21%	-53.54%	-76.64%
Earnings Yield	-0.30%	-42.70%	-90.90%	-53.20%	-8.09%	-
FCF Yield	-0.70%	-28.20%	-86.61%	-48.30%	-6.84%	-
Buyback Yield / Dilution	-29.26%	-15.87%	-50.57%	-37.64%	-148.42%	-74.24%
Total Shareholder Return	-29.26%	-15.87%	-50.57%	-37.64%	-148.42%	-74.24%

Source: S&P Capital IQ. Standard template. Financial Sources.